Imaging-based Quantification of Hepatic Fat: Methods and Clinical Applications
- 1 September 2009
- journal article
- review article
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 29 (5), 1253-1277
- https://doi.org/10.1148/rg.295085186
Abstract
Fatty liver disease comprises a spectrum of conditions (simple hepatic steatosis, steatohepatitis with inflammatory changes, and end-stage liver disease with fibrosis and cirrhosis). Hepatic steatosis is often associated with diabetes and obesity and may be secondary to alcohol and drug use, toxins, viral infections, and metabolic diseases. Detection and quantification of liver fat have many clinical applications, and early recognition is crucial to institute appropriate management and prevent progression. Histopathologic analysis is the reference standard to detect and quantify fat in the liver, but results are vulnerable to sampling error. Moreover, it can cause morbidity and complications and cannot be repeated often enough to monitor treatment response. Imaging can be repeated regularly and allows assessment of the entire liver, thus avoiding sampling error. Selection of appropriate imaging methods demands understanding of their advantages and limitations and the suitable clinical setting. Ultrasonography is effective for detecting moderate or severe fatty infiltration but is limited by lack of interobserver reliability and intraobserver reproducibility. Computed tomography allows quantitative and qualitative evaluation and is generally highly accurate and reliable; however, the results may be confounded by hepatic parenchymal changes due to cirrhosis or depositional diseases. Magnetic resonance (MR) imaging with appropriate sequences (eg, chemical shift techniques) has similarly high sensitivity, and MR spectroscopy provides unique advantages for some applications. However, both are expensive and too complex to be used to monitor steatosis.Keywords
This publication has 99 references indexed in Scilit:
- Respiratory motion-corrected proton magnetic resonance spectroscopy of the liverMagnetic Resonance Imaging, 2009
- Liver Steatosis: Investigation of Opposed-Phase T1-weighted Liver MR Signal Intensity Loss and Visceral Fat Measurement as BiomarkersRadiology, 2008
- Liver fat is reproducibly measured using computed tomography in the Framingham Heart StudyJournal of Gastroenterology and Hepatology, 2008
- Ultrasound Diagnosis of Fatty Liver in Patients With Chronic Liver DiseaseJournal of Clinical Gastroenterology, 2007
- Hepatic Steatosis Is a Risk Factor for Postoperative Complications After Major HepatectomyAnnals of Surgery, 2007
- Steatosis as a Risk Factor in Liver SurgeryAnnals of Surgery, 2007
- Impact of steatosis on progression of fibrosis in patients with mild hepatitis CHepatology, 2004
- The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsiesJournal of Hepatology, 2004
- Long-Term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis CHepatology, 2003
- Computed tomography attenuation values in fatty liverJournal of Computed Tomography, 1981